GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXA) » Definitions » Tax Expense

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Tax Expense : $0.04 Mil (TTM As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition Tax Expense?

Lux Health Tech Acquisition's tax expense for the months ended in Jun. 2022 was $0.04 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2022 was $0.04 Mil.


Lux Health Tech Acquisition Tax Expense Historical Data

The historical data trend for Lux Health Tech Acquisition's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition Tax Expense Chart

Lux Health Tech Acquisition Annual Data
Trend Dec20 Dec21
Tax Expense
- -

Lux Health Tech Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Tax Expense Get a 7-Day Free Trial - - - - 0.04

Lux Health Tech Acquisition Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lux Health Tech Acquisition  (NAS:LUXA) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Lux Health Tech Acquisition Tax Expense Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
920 Broadway, 11th Floor, New York, NY, USA, 10010
Lux Health Tech Acquisition Corp is a blank check company.
Executives
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo director, officer: Chief Executive Officer 1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert director, 10 percent owner C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh director C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough officer: CFO and Treasurer C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines